{"id":"atorvastatin-lipitor","safety":{"commonSideEffects":[{"rate":"2–3","effect":"Myalgia (muscle pain)"},{"rate":"1–3","effect":"Elevated liver enzymes (ALT/AST)"},{"rate":"<0.1","effect":"Rhabdomyolysis (rare)"},{"rate":"1–2","effect":"Headache"},{"rate":"1–2","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By blocking HMG-CoA reductase, atorvastatin decreases hepatic cholesterol production and upregulates LDL receptors on liver cells, enhancing clearance of LDL cholesterol from circulation. This leads to reduced plasma LDL levels and decreased cardiovascular risk. It also has modest effects on triglycerides and HDL cholesterol.","oneSentence":"Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:46.038Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia (primary and secondary prevention)"},{"name":"Coronary heart disease and acute coronary syndromes"},{"name":"Stroke prevention in high-risk patients"}]},"trialDetails":[{"nctId":"NCT07497776","phase":"PHASE4","title":"Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome","status":"COMPLETED","sponsor":"National Institute of Kidney Disease and Urology (NIKDU)","startDate":"2024-01-27","conditions":"Dyslipidaemia","enrollment":100},{"nctId":"NCT05488067","phase":"PHASE4","title":"Atorvastatin Therapy on Xanthoma in Alagille Syndrome","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2022-03-22","conditions":"Alagille Syndrome, Atorvastatin, Xanthoma","enrollment":15},{"nctId":"NCT02432534","phase":"PHASE2","title":"Atorvastatin in Active Vitiligo","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2015-05","conditions":"Vitiligo","enrollment":28},{"nctId":"NCT07489183","phase":"","title":"A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older","status":"COMPLETED","sponsor":"Dong Wha Pharmaceutical Co. Ltd.","startDate":"2021-08-23","conditions":"Hypercholesterolemia","enrollment":641},{"nctId":"NCT07474649","phase":"PHASE3","title":"A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events","status":"NOT_YET_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2026-06-01","conditions":"Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia","enrollment":103},{"nctId":"NCT04862260","phase":"EARLY_PHASE1","title":"Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2021-10-04","conditions":"Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer","enrollment":3},{"nctId":"NCT07400757","phase":"NA","title":"Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2026-02-20","conditions":"Thyroid Eye Disease, TED, Graves Ophthalmopathy","enrollment":120},{"nctId":"NCT07045142","phase":"PHASE3","title":"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-07-01","conditions":"Schizophrenia","enrollment":400},{"nctId":"NCT06157099","phase":"PHASE2","title":"Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2024-09-01","conditions":"Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIB Cutaneous Melanoma AJCC v8","enrollment":150},{"nctId":"NCT07359105","phase":"NA","title":"Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)","status":"RECRUITING","sponsor":"Sin Gon Kim","startDate":"2026-03-09","conditions":"Dyslipidemia Associated With Type II Diabetes Mellitus","enrollment":2186},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT04915183","phase":"PHASE2","title":"Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer","status":"RECRUITING","sponsor":"National Institute on Deafness and Other Communication Disorders (NIDCD)","startDate":"2024-07-10","conditions":"Hearing Loss, Head and Neck Cancer","enrollment":224},{"nctId":"NCT06686615","phase":"","title":"A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","status":"RECRUITING","sponsor":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","startDate":"2025-02-12","conditions":"Primary Hypercholesterolemiia, Mixed Dyslipidemia","enrollment":2000},{"nctId":"NCT06308952","phase":"PHASE4","title":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","status":"RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2024-07-30","conditions":"Cerebrovascular Event, Stent Stenosis, Ischemic Stroke","enrollment":354},{"nctId":"NCT06696820","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Xiang Luo","startDate":"2024-11-29","conditions":"Acute Ischemic Stroke","enrollment":429},{"nctId":"NCT07268625","phase":"PHASE1","title":"Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-12-09","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT06841536","phase":"NA","title":"Combined Effects of Statins and Exercise on Training Sensitive Health Markers","status":"COMPLETED","sponsor":"University of the Faroe Islands","startDate":"2025-05-01","conditions":"Dyslipidemias","enrollment":120},{"nctId":"NCT06764966","phase":"PHASE2","title":"Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis","status":"RECRUITING","sponsor":"CAMC Health System","startDate":"2025-09-09","conditions":"Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver","enrollment":50},{"nctId":"NCT04747847","phase":"EARLY_PHASE1","title":"Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2019-06-22","conditions":"Kawasaki Disease","enrollment":5},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT06248671","phase":"PHASE2","title":"Prophylactic Treatment With Atorvastatin for Episodic Migraine.","status":"RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2024-05-01","conditions":"Episodic Migraine","enrollment":450},{"nctId":"NCT05289063","phase":"PHASE1","title":"Vascular Endothelial Dysfunction in Sleep Apnea","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-10-03","conditions":"Obstructive Sleep Apnea of Adult","enrollment":110},{"nctId":"NCT07389304","phase":"PHASE1","title":"[Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers]","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Lipid Profile,Blood Pressure","enrollment":100},{"nctId":"NCT07235189","phase":"PHASE1","title":"A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2025-10-28","conditions":"Healthy Subjects","enrollment":58},{"nctId":"NCT07378228","phase":"NA","title":"Weak Pulse at Yang and Wiry Pulse at Yin Theory","status":"COMPLETED","sponsor":"Xikun Li","startDate":"2023-07-01","conditions":"Coronary Heart Disease, Stable Angina Pectoris","enrollment":70},{"nctId":"NCT07378293","phase":"PHASE1","title":"Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Shaheed Benazir Bhutto University Sheringal Dir Upper","startDate":"2026-03-01","conditions":"Diabete Mellitus, Lipid Profile","enrollment":100},{"nctId":"NCT04735263","phase":"PHASE2","title":"Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-02-04","conditions":"Age-related Macular Degeneration","enrollment":21},{"nctId":"NCT07303699","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2026-01-03","conditions":"Pulmonary Tuberculosis (TB)","enrollment":80},{"nctId":"NCT07362030","phase":"PHASE1","title":"Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Raynovent Biotech Co., Ltd","startDate":"2025-04-14","conditions":"Obesity","enrollment":32},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT06372925","phase":"PHASE4","title":"Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-09","conditions":"Plaque, Atherosclerotic","enrollment":318},{"nctId":"NCT04767984","phase":"PHASE2","title":"Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2021-09-24","conditions":"Colorectal Carcinoma, Ulcerative Colitis","enrollment":42},{"nctId":"NCT04679376","phase":"PHASE2","title":"Statins for the Treatment of NASH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-01-25","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":70},{"nctId":"NCT06553157","phase":"PHASE1, PHASE2","title":"Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":"Solid Tumors, Ototoxicity","enrollment":56},{"nctId":"NCT07344610","phase":"","title":"Effects of Short-term Intensive Statin Therapy on Lipid Levels","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-08","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT06782243","phase":"NA","title":"Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-20","conditions":"Acute Coronary Syndrome","enrollment":190},{"nctId":"NCT05462262","phase":"NA","title":"Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2022-10-10","conditions":"Coronary Artery Disease Progression","enrollment":2900},{"nctId":"NCT07307989","phase":"PHASE2","title":"Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-08-01","conditions":"Ischemic Stroke, Hypercholesteremia","enrollment":300},{"nctId":"NCT06501443","phase":"PHASE4","title":"LATAM LOWERS LDL-C","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-02-11","conditions":"Hypercholesterolaemia","enrollment":520},{"nctId":"NCT05641753","phase":"PHASE4","title":"Cholesterol Lowering and Residual Risk in Diabetes, Type 1","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-06","conditions":"Type 1 Diabetes","enrollment":125},{"nctId":"NCT07301372","phase":"PHASE4","title":"Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke","status":"RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2025-10-30","conditions":"Acute Stroke","enrollment":132},{"nctId":"NCT05826912","phase":"PHASE2","title":"Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Francisco","startDate":"2024-08-01","conditions":"Traumatic Brain Injury","enrollment":672},{"nctId":"NCT05877235","phase":"NA","title":"Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:","status":"COMPLETED","sponsor":"InCor Heart Institute","startDate":"2021-10-03","conditions":"Coronary Artery Disease, Menopause","enrollment":60},{"nctId":"NCT06615284","phase":"PHASE1","title":"A Study of Atorvo+™ in Healthy Adult Participants","status":"COMPLETED","sponsor":"Indication Bioscience LLC","startDate":"2025-01-28","conditions":"Coronary Heart Disease, Dyslipidemias","enrollment":24},{"nctId":"NCT07290699","phase":"PHASE4","title":"Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Nanchang University","startDate":"2026-01-01","conditions":"STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)","enrollment":2442},{"nctId":"NCT06896708","phase":"NA","title":"Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome","status":"RECRUITING","sponsor":"Liu yong","startDate":"2025-08-12","conditions":"Chronic Coronary Syndrome","enrollment":766},{"nctId":"NCT07278830","phase":"PHASE2","title":"A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2023-06-02","conditions":"Hypercholesterolemia and Mixed Dyslipidemia","enrollment":214},{"nctId":"NCT07265466","phase":"PHASE1","title":"to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban","status":"RECRUITING","sponsor":"Onconic Therapeutics Inc.","startDate":"2025-11-17","conditions":"Drug Drug Interaction (DDI)","enrollment":96},{"nctId":"NCT07012629","phase":"PHASE3","title":"A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2025-11-26","conditions":"Covert Brain Infarction","enrollment":1652},{"nctId":"NCT07042165","phase":"PHASE4","title":"Treatment of Bile Acid Diarrhoea With Atorvastatin","status":"RECRUITING","sponsor":"Asger Lund, MD","startDate":"2025-10-15","conditions":"Bile Acid Diarrhea, Bile Acid Malabsorption","enrollment":20},{"nctId":"NCT06791031","phase":"NA","title":"PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2026-01","conditions":"Coronary Artery Disease","enrollment":212},{"nctId":"NCT05910476","phase":"PHASE4","title":"Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2023-05-03","conditions":"Coronary Artery Disease, Dyslipidemias","enrollment":200},{"nctId":"NCT05567068","phase":"PHASE2","title":"Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-02-01","conditions":"Inflammatory Bowel Diseases","enrollment":54},{"nctId":"NCT06336174","phase":"","title":"Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2022-11-01","conditions":"Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular Event","enrollment":100},{"nctId":"NCT04626973","phase":"NA","title":"Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2021-01-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":3048},{"nctId":"NCT05559164","phase":"PHASE2","title":"Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2022-09-19","conditions":"Cardiac Toxicity, Early-stage Breast Cancer","enrollment":60},{"nctId":"NCT04262206","phase":"PHASE4","title":"Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-09-01","conditions":"Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases","enrollment":20000},{"nctId":"NCT06632379","phase":"PHASE4","title":"AtorvaStatin Postpartum and Reduction of Cardiovascular risK","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2025-10-03","conditions":"Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension","enrollment":76},{"nctId":"NCT06948747","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-06","conditions":"Healthy Participants","enrollment":49},{"nctId":"NCT06369571","phase":"PHASE1, PHASE2","title":"Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet","status":"ENROLLING_BY_INVITATION","sponsor":"Johns Hopkins University","startDate":"2024-10-04","conditions":"Epilepsy, Dyslipidemia","enrollment":22},{"nctId":"NCT06961630","phase":"EARLY_PHASE1","title":"Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-10-07","conditions":"Myocardial Injury After Noncardiac Surgery","enrollment":50},{"nctId":"NCT07197463","phase":"NA","title":"The Therapeutic Effect of Phase I Cardiac Rehabilitation on Elderly Patients With CHD Complicated by Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2025-10-10","conditions":"Coronary Disease, Sarcopenia","enrollment":100},{"nctId":"NCT06199921","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2024-01-03","conditions":"Pulmonary Tuberculosis, Tuberculosis, Koch's Disease","enrollment":440},{"nctId":"NCT05028829","phase":"PHASE2","title":"Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk","status":"RECRUITING","sponsor":"Raymond Chung","startDate":"2023-05-10","conditions":"Liver Fibroses, Cirrhosis","enrollment":60},{"nctId":"NCT07180745","phase":"PHASE4","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2025-11-01","conditions":"Non-alcoholic Fatty Liver Disease NAFLD, Non-alcoholic Steatohepatitis NASH","enrollment":400},{"nctId":"NCT05559606","phase":"","title":"An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe","status":"COMPLETED","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2022-09-07","conditions":"Primary Hypercholesterolemia","enrollment":1839},{"nctId":"NCT02958852","phase":"PHASE2","title":"A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"Lund University Hospital","startDate":"2025-01-02","conditions":"Breast Cancer","enrollment":126},{"nctId":"NCT05761444","phase":"PHASE4","title":"Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2023-07-26","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":137},{"nctId":"NCT06358313","phase":"PHASE3","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Moderate and Moderate-to-severe Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT06360120","phase":"PHASE3","title":"Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-10","conditions":"Ischemic Stroke","enrollment":600},{"nctId":"NCT02314208","phase":"PHASE2","title":"Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2015-01-08","conditions":"Spastic Paraplegia, Hereditary","enrollment":12},{"nctId":"NCT07148037","phase":"","title":"Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-09-01","conditions":"Hyperlipidemias","enrollment":150},{"nctId":"NCT02603328","phase":"PHASE1, PHASE2","title":"Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-07-17","conditions":"Cerebral Cavernous Malformation","enrollment":80},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT07128212","phase":"NA","title":"Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1","status":"COMPLETED","sponsor":"Suzhou Municipal Hospital of Anhui Province","startDate":"2021-01-01","conditions":"Ischemic White Matter Lesions (WMIL), Cerebral Small Vessel Disease, Vascular Cell Adhesion Molecule-1","enrollment":401},{"nctId":"NCT04111419","phase":"PHASE4","title":"Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-07-01","conditions":"Atrial Fibrillation, Hypertension","enrollment":1200},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT05561062","phase":"PHASE2","title":"Atorvastatin in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":"Inflammatory Bowel Diseases","enrollment":50},{"nctId":"NCT04379999","phase":"EARLY_PHASE1","title":"Atorvastatin ± Aspirin in Lynch Syndrome Syndrome","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"2018-09-10","conditions":"Lynch Syndrome","enrollment":43},{"nctId":"NCT06902740","phase":"PHASE4","title":"PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-09-01","conditions":"Intracranial Atherosclerosis, Intracranial Artery Stenosis, Atherosclerotic Plaque","enrollment":300},{"nctId":"NCT07083206","phase":"","title":"A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe","status":"RECRUITING","sponsor":"Ahn-Gook Pharmaceuticals Co.,Ltd","startDate":"2025-07-29","conditions":"Hypercholesterolemia, Dyslipidemias","enrollment":4500},{"nctId":"NCT06567327","phase":"PHASE1","title":"A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-08-28","conditions":"Obesity","enrollment":82},{"nctId":"NCT04765137","phase":"PHASE2","title":"Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-05-21","conditions":"Mild Cognitive Impairment","enrollment":20},{"nctId":"NCT05030818","phase":"PHASE4","title":"Cross-over Study of Coronary Risk Factors With a Polypill","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2022-10-14","conditions":"Coronary Artery Disease","enrollment":88},{"nctId":"NCT06858332","phase":"","title":"Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-04-15","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":2382},{"nctId":"NCT04251364","phase":"NA","title":"Treatment of Chronic Mountain Sickness","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2020-02-15","conditions":"Hypoxia, Altitude","enrollment":60},{"nctId":"NCT06789432","phase":"PHASE4","title":"Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population","status":"RECRUITING","sponsor":"Dr. Md. Alimur Reza","startDate":"2025-02-01","conditions":"Hyperlipidemia (E.G., Hypercholesterolemia)","enrollment":500},{"nctId":"NCT07088250","phase":"NA","title":"Statins for Treatment of Primary Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"The Second Hospital of Anhui Medical University","startDate":"2023-05-06","conditions":"Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage","enrollment":264},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT07087379","phase":"PHASE4","title":"Perioperative Intensive Statin Therapy for Neuroprotection in TAVR（PISTNT）","status":"NOT_YET_RECRUITING","sponsor":"Pan Xiangbin","startDate":"2025-10-01","conditions":"Aortic Stenosis, Cerebral Ischaemic Injury","enrollment":500},{"nctId":"NCT06922994","phase":"PHASE2","title":"Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)","status":"RECRUITING","sponsor":"Centro Cardiologico Monzino","startDate":"2025-03-31","conditions":"Arrhythmogenic Cardiomyopathy","enrollment":102},{"nctId":"NCT06690164","phase":"PHASE4","title":"Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-06-12","conditions":"Metabolite","enrollment":78},{"nctId":"NCT06485336","phase":"PHASE2","title":"Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)","status":"RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2024-05-01","conditions":"Chronic Migraine","enrollment":300},{"nctId":"NCT05796973","phase":"PHASE3","title":"Measuring Oncological Value of Exercise and Statin","status":"RECRUITING","sponsor":"Tampere University Hospital","startDate":"2023-03-31","conditions":"Prostate Cancer, Breast Cancer, Kidney Cancer","enrollment":240},{"nctId":"NCT03819101","phase":"PHASE3","title":"Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2019-06-06","conditions":"Prostate Cancer","enrollment":1210},{"nctId":"NCT07036991","phase":"PHASE4","title":"Clinical Trial of PCSK9 Inhibitor and Statin Treatment for Carotid Artery Stenosis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-07-30","conditions":"Carotid Artery Stenosis","enrollment":406},{"nctId":"NCT04972396","phase":"PHASE1","title":"Pemvidutide (ALT-801) DDI Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Altimmune, Inc.","startDate":"2021-09-15","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":40},{"nctId":"NCT06723691","phase":"PHASE1","title":"Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects","status":"COMPLETED","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-12-18","conditions":"Type 2 Diabetes","enrollment":57}],"_emaApprovals":[],"_faersSignals":[{"count":10,"reaction":"DYSPNOEA"},{"count":7,"reaction":"NAUSEA"},{"count":6,"reaction":"PNEUMONIA"},{"count":5,"reaction":"ACUTE KIDNEY INJURY"},{"count":5,"reaction":"ATRIAL FIBRILLATION"},{"count":5,"reaction":"DIARRHOEA"},{"count":5,"reaction":"FATIGUE"},{"count":4,"reaction":"ACUTE RESPIRATORY FAILURE"},{"count":4,"reaction":"CHEST PAIN"},{"count":4,"reaction":"CHRONIC KIDNEY DISEASE"}],"_approvalHistory":[],"publicationCount":69,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lipitor","ATV (Lipitor ®)"],"phase":"marketed","status":"active","brandName":"Atorvastatin (Lipitor)","genericName":"Atorvastatin (Lipitor)","companyName":"University of Chicago","companyId":"university-of-chicago","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Atorvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, thereby reducing LDL cholesterol levels in the blood. Used for Hypercholesterolemia (primary and secondary prevention), Coronary heart disease and acute coronary syndromes, Stroke prevention in high-risk patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}